chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next morning (10/1/09), I woke up very, very cold. (The first symptom I often have when sick is that my body temperature drops one or two  degrees.) After that passed (after 3 blankets and something hot to drink), I was fine until afternoon: took an hour nap and felt groggy and tired when I woke up. Late afternoon, I felt tired but drove to where I teach two evening classes. Symptoms included: extreme fatigue, dizziness, some lack of motor coordination, headache, mild nausea. I cancelled classes for the night, went home, and slept 12 hours. Today (10/2) I still feel dizzy and tired, but somewhat better. I had NO flu symptoms before the flu shot. By noon, I was back in bed.
Hyperinsulinemia; Extra Pediarix dose; This serious case was reported by a nurse via call center representative and described the occurrence of hyperinsulinemia in a 6-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 25L32, expiry date 28-MAR-2025) for prophylaxis.   Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number 25L32, expiry date 28-MAR-2025) for prophylaxis.   Previously administered products included Vaxellis. Concomitant products included PEDIARIX.   On 26-APR-2023, the patient received the 4th dose of Pediarix. On 02-FEB-2023, the patient received the 2nd dose of Pediarix. On 27-MAR-2023, not applicable after receiving Pediarix and 53 days after receiving Pediarix, the patient experienced hyperinsulinemia (Verbatim: Hyperinsulinemia) (serious criteria hospitalization and clinically significant/intervention required). On 26-APR-2023, the patient experienced extra dose administered (Verbatim: Extra Pediarix dose) (serious criteria hospitalization and clinically significant/intervention required). The outcome of the hyperinsulinemia was resolved and the outcome of the extra dose administered was unknown.   The reporter considered the hyperinsulinemia to be unrelated to Pediarix and Pediarix Pre-Filled Syringe Device.   The company considered the hyperinsulinemia to be unrelated to Pediarix and Pediarix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-APR-2023 The patient was hospitalized for Hyperinsulinemia on 27th March 2023 and received the 6-month Pediarix shot there. On the day of reporting the patient went for her physical, and then received the extra Pediarix (4th dose). Although the Healthcare professional stated that the Hyperinsulinemia was unrelated to the Pediarix, it was corrected by surgery. The reporter also mentioned that the 1st dose, the patient received was Vaxelis, and the last 3 were Pediarix. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal. The patient received 4th dose as Pediarix which led to extra dose administered.
2 year old received H1N1 vaccine morning of 11/13/2009, at 7:20 Pm she began vomiting, was afebrile at the time.  Numerous attempts were made to contact parents and messages were left, no return calls and no further information could be obtained.
Patient complained of localized swelling and redness at the site and also fever that started the same night that he was given the vaccine. Patient was treated on 9/20/17 with Bactrim DS Tablet, 800-160 MG and IV with normal saline and Rocephin 1 gram IV pushed. Patient also instructed to do warm compresses at home. Patient was also seen on 9/21/17 and given Rocephin 1 gram and Vancomycin 1 gram through normal saline and 9/22/17 with IV normal saline and rocephin 1 gram.
Brain fog; Headache; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:30 as dose 1, single for COVID-19 immunisation (Age at vaccination was 31 years). The patient medical history was none and no known allergies. The patient concomitant medications were not reported. It was reported that, she did not receive any other vaccine in four weeks and no other medications in two weeks prior COVID vaccine. She was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. She was not a pregnant at the time of vaccination. On 22Feb2021 14:00, the patient experienced brain fog, headache, and fatigue. No therapeutic measures were taken as a result of events. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Patient reported having hardness (3-4 inch area) and warmth at the injection site the day of the vaccine injection into the left deltoid (PNEUMOVAX). On 9-18-18, the hardness spread to the inner part of the arm and the warmth continued. Also, she noticed her arm started getting red and "splotchy." The patient immediately took BENADRYL in case she was indeed having an allergic reaction. BENADRYL seemed to have helped with the redness and rash. The patient called the pharmacy on 9-19-18 to report her findings and the hardness seems to have gone done a bit (2-3 inch area) at the injection site. Reporter also notified her PCP to document in her chart.
Pt c/o nausea 14 mins after receiving first dose of the vaccine. She denies any past medical Hx and noted that she ate this AM. She was assessed and monitored by NP, EMT, and paramedic. Initial BP - 142/101, HR - 90, O2 sat 97% on RA. She had mild anxiety.
No adverse effects; a patient was administered improperly stored PROQUAD; This spontaneous report was received from a medical assistant and refers to a 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 04-SEP-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S009759 has been verified to be a valid lot number, expiration date 27-SEP-2020, recombinant Human albumin (exact dose, dose number, route and site of administration were not reported) for prophylaxis. The sterile diluent that was used to reconstitute the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) vaccine was properly stored. No adverse effect was reported.  Administered dose of vaccine were exposed to the temperature excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (17.6 degrees Fahrenheit) for 56 hours and 40 minutes. Data logger was not involved. There was previous temperature excursions of 6 degrees Fahrenheit to 14 degrees Fahrenheit (6.2 degrees Fahrenheit) for 10 minutes. There was no adverse effects reported.
Has to use more insulin since receiving the COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Has to use more insulin since receiving the COVID-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Diabetes.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE DECREASED (Has to use more insulin since receiving the COVID-19 vaccine). At the time of the report, BLOOD GLUCOSE DECREASED (Has to use more insulin since receiving the COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-035936 (Patient Link).   Reporter did not allow further contact
APPROXIMATELY 3 MINS. POST VACCINATION CLIENT COMPLAINED OF SEVERE ITCHING AFTER BANDAID APPLIED TO INJECTION SITE, NOTED APPROX. 7 CM REDDENED, SLIGHTLY RAISED AREA TO RIGHT UPPER ARM. IMMEDIATELY EVAL PER PHYSICIAN. CLIENT ALERT, AWAKE, AND ORIENTED WITHOUT ANY RESP. DISTRESS. ADULT PARENT ACCOMPANYING. MD EVAL. CLIENT ADVISED BENADRYL INJEC. CLIENT AND PARENT DECLINED THIS TREATMENT, PLAN TO TAKE OTC BENADRYL. LEFT WITHOUT ANY FURTHER PROBLEMS. CLIENT PARENT CALLED BACK @1:30PM, FEELING BETTER AFTER TAKING OTC BENADRYL, SWELLING DECREASING AND ITCHING HAS COMPLETELY SUBSIDED. THANKS.
Patient got erythematous rash-covering whole body 3 days after MMR and VZV. The rash is urticarial.
Dry throat immediately.  Sinus pain, ear pain, teeth pain, and neck pain increasing.  Injection site pain
Headache, Arthralgia, Fever,  Palpitations, pre-syncope
FEVER >100F, CHILLS, ACHES LASTING 2-3 DAYS
Patient states that her arm is still sore after receiving flu shot 4 months ago. The tricep in the vaccinated arm is sore and she reports it getting stiff.
First day after injection arm was extremely sore.  That last just one day.  about 5 days later injection site became very red, hard, warm to touch and extremely itchy.
Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
fever 6MAY (not measured);achy joints,always has enlarged submandibular glands,maculopapular rash on torso-upper legs,arms,neck;rash lasted only a few hrs
Pt recv vax on 2/25/99; on same day pt exp irritable, consistent crying >3 hr; dx=colic; tx=unspecified medicine
This case was reported by a physician, via a GSK sales representative, that described the occurrence of excessive screaming in a 2-month-old subject of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (PEDIARIX, GlaxoSmithKline) for prophylaxis. In March 2008, the subject received the 1st dose of PEDIARIX (.5 ml, unknown). Within one hour after vaccination with PEDIARIX, the subject experienced a screaming reaction, described as "unconsolable non-stop screaming", which lasted for a period of several hours. At the time of reporting the event was resolved. The reporting physician considered the event was probably related to vaccination with PEDIARIX. Follow-up information was received on 23 May 2008 via a registered nurse, who indicated that this case was reported to a Regulatory Agency (VAERS I #308873). The nurse reported that the subject was a 2-month-old male who was vaccinated with PEDIARIX on the morning of 08 February 2008. The subject's medical history included increased bilirubin levels. Concurrent medical conditions included gastroesophageal reflux. Concurrent vaccinations given on 08 February 2008 included(ACTHIB, manufacturer unspecified); unknown; left thigh; (ROTATEQ, manufacturer unspecified); oral; and (PREVNAR, manufacturer unspecified); unknown; left thigh. The excessive screaming was reported to the physician's office via a phone call on 08 February 2008 at 14:45. The subject was treated with two doses of Tylenol, four hours apart. The events were reported to be improved, then resolved as of 09 February 2008. The immunization series with PEDIARIX was discontinued. The reporting nurse considered the event to be related to vaccination with PEDIARIX.
On 07/26/2000 and on 08/16/2000 the patient was vaccinated with a first and second dose of varicella virus vaccine live, respectively. It was reported that the patient was tested in the physician's office and was found to have a negative varicella antibody prior to and after the second dose of varicella virus vaccine live. Additional information has been requested.
Common side-effect of arm pain following covid vaccination never completely subsided. My arm still aches as if there is a deep bruise and certain motions cause a shooting pain in the muscle. I cannot perform motions with my arm overhead without pain and there is weakness in my arm that was never there before said vaccination.
Lymph node enlarged at the base of neck near the shoulder; Chills; Nausea; Sore arm; patient received vaccine right below shoulder bone; A spontaneous report was received from a nurse, a 60 year old female patient who received Moderna's COVID-19 mRNA-1273 vaccine at inappropriate site of vaccination and who experienced chills (Chills), nausea (Nausea), sore arm (pain in extremity) and enlarged lymph nodes at base of neck and shoulder (Lymphadenopathy).  The patient's medical history included prior dose of Covid-19 vaccination. No adverse event was reported in the medical history of the patient.  Concomitant medications were not reported.  On 05 Jan 2021, the patient received first of the two planned doses of mRNA-1273 (Batch number:011L20A) for the prophylaxis of Covid-19 infection. No adverse event was reported related to the first dose.  On 02 Feb 2021, the prior to the onset of the events, the patient received second of their two planned doses of mRNA-1273 (Lot number:007M20A) at inappropriate site of vaccination (right below the shoulder bone).  On 03 Feb 2021,the patient reported to experience chills(Chills), nausea(Nausea), sore arm(pain in extremity) and enlarged lymph nodes at base of neck and shoulder (Lymphadenopathy).  Treatment for the events were not reported.  The outcome of the event inappropriate site of vaccination was considered to be resolved on 08 Feb 2021.  The outcome of the events chills (Chills), nausea (Nausea), sore arm (pain in extremity) and enlarged lymph nodes at base of neck and shoulder (Lymphadenopathy) was considered not resolved.; Reporter's Comments: This case concerns a 60-year-old female who had a nonserious unexpected Product administered at inappropriate site along with nonserious expected pain in extremity, lymphadenopathy, nausea, and chills.  Event onset was 1 day after second dose and 29 days after first dose of mRNA-1273. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Initial information has been received from a physician via field representative concerning a 65 years old female patient with an unspecified pertinent medical history or drug reactions/allergies. On an unspecified date in 2010, the patient was vaccinated with a 0.65 ml (one) dose of ZOSTAVAX (route and lot number were not reported). No other suspect medications were reported. No concomitant medications were reported. On 04-FEB-2013 the patient "got shingles". The patient was treated with acyclovir. Laboratory studies were not reported. The patient sought medical attention by visiting office. The patient outcome was unknown. Additional information has been requested.
Within 10 minutes of injection throat swellin, chest tighting. 10 minutes to 10 hours of injection above symptoms plus hives, itching and rash. One week rask and itchy eyes.
Aura, headache, lip and tongue tingling, started within minutes. Resolved over a few days.
This young lady began having symptoms of a cough with SOB yesterday at 22:00. The cough became more moderate in nature throughout the night, waking her up several times. She also woke up with a sore throat and had a generalized weak feeling this AM. Still having symptoms above at 14:45 on 6/8/06. She has not used inhaler or breathing treatment. Seen at hospital on 6/8/06 ER and given breathing treatments X 3 and symptoms, as above, resolved.
Patient experienced pain at time of injection and pain at injection site. He described feeling like it hit a nerve. Over time the tingling has subsided but he still experiences pain with the nerve a year later.
Moderna COVID-19 Vaccine EUA Chills Nausea Headache Fever - 101.6 Tiredness Took Tylenol, stayed out of work 1 day and rested
Mom said the night of admin of vaccine, felt numbness and tingling sensation in fingers and toes. Whole hand and foot then begin to feel numbness. Trembling and shaking in legs. Torso was shaking as well. Took to ED, everything was okay, vitals were okay, not concern. On the way to the hospital, mom said heart rate was high and skipping beats, they ran EKG and everything was okay.
I started having a really bad sore throat on February 22, 2022. I had lost my voice completely. My voice came back about several days after that. I felt really bad. I had flu like symptoms with drainage and coughing. I had no fever. The phlegm was turning into a greenish yucky color. I made an appointment to see Dr. on March 1, 2022. He diagnosed me with walking pneumonia. I was prescribed an antibiotic called Doxycycline 100mg 2xday. I was also prescribed Methylprednisolone for 6 days. I gradually got better after I started taking the medications.
This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 18Apr2021 at 10:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included moderate asthma from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included formoterol fumarate, mometasone furoate (DULERA), cyclobenzaprine (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); all for unspecified indication from an unknown date. The patient had no allergies to food, medication or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 28Mar2021 at 10:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced pain at injection site, tiredness, headache, muscle pain and nausea. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain at injection site, tiredness, headache, muscle pain and nausea were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.
Vaccinee a non responder p/a series of 3 doses of Engerix-B IM/Deltoid). tx: none. outcome: pending.
I got my second Pfizer booster for COVID-19 on 4/19/2022. About three days later, I began to feel nauseous, and I don't know why. I also had throat discomfort. I drank prune juice and ate raisins in an effort to ease the nausea, but it didn't work. About three or four days later, I felt queasy, so I took some TUMS. I then had diarrhea. I felt a little better after going to the bathroom, but I still felt a bit queasy. On 5/10/2022, I went to an urgent care clinic. I was diagnosed with acid reflux and prescribed medication. I was told to do a follow-up with my PCP. On 5/29/2022, I had a follow-up with my PCP over the phone. My PCP told me to finish my medication, and I was referred to a nutritionist, whom I'm scheduled to see on 6/2/2022. My PCP told me that if my symptoms worsened, he would refer to a gastroenterologist. Since I've been taking the medication and following dietary recommendations, my reflux symptoms have been milder and I've felt less of a burning sensation.
Site: Pain at Injection Site-Mild, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Fever-Severe, Systemic: Fainting/fever of 104-Severe, Systemic: Hypotension-Medium, Additional Details: Patient recieved vaccine and waited 15 minutes in store. She then left and later that night experienced 104 degree fever. Patient thereafter fainted. One of her family members took her to the ER where she was treated. Patient's caregiver reported this incident on 2.12.22. Caregiver brought in script from ER for ibuprofen 800 and Tylenol 325 mg.
tightening of chest, shortness of breathe, numbness/tingling in fingers and lips
Received three immunizations in the arms on 8/18/08 on Wed. the 20th he developed a high fever of 103f and severe pain all the way down both legs starting at the waist and down both legs. Legs were very painful to touch. By Thurs. the 21st the fever and leg pains were gone and just had mild soreness at injection sites on arms.
I noticed round knots right above my collar bone. Then I started having pain on my left side of my under arm and the arm itself. My whole left arm was in pain. I also can be in pain when doing a workout. My arm really hurts so bad at night. I had went to the doctors and they told me that my lymph nodes were swollen. I had a biopsy on January 21, 2022. I was told they my swollen lymph nodes may be malignant. Back in 2000 I did have cancer on the left side of my body. Since getting the biopsy I am still in pain and it seems like as time goes on the pain is getting worse. I didn't have any energy today, and it feels like I didn't have the stamina I had before. I workout everyday, but since receiving the vaccine it has been a struggle to workout like I used to.
none Given expired covid 19 vaccine. EXPIRED 11/22/2022 GIVEN 12/19/2022
Injection site reaction with cellulitis at injection site. Treated with 500mg KEFLEX.